POST SORAFENIB SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: THE ROLE OF TUMOR PROGRESSION AND LIVER IMPAIRMENT

被引：0
|
作者：
Iavarone, M. [1 ]
Cabibbo, G. [2 ]
Biolato, M. [3 ]
Della Corte, C. [1 ]
Maida, M. [2 ]
Basso, M. [3 ]
Vavassori, S. [1 ]
Camma, C. [2 ]
Grieco, A. [3 ]
Craxi, A. [2 ]
Colombo, M. [1 ]
机构：
[1] Univ Milan, AM &A Migliavacca Ctr Liver Dis, Fdn IRCCS Ca Granda Maggiore Hosp, Div Gastroenterol 1, Milan, Italy
[2] Univ Palermo, Gastroenterol Sect, DIBIMIS, Policlin P Giaccone, Palermo, Italy
[3] UCSC Catholic Univ Rome, Dept Internal Med, Gemelli Hosp, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2014年 / 46卷
关键词：
D O I：
10.1016/j.dld.2014.01.082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T-42
引用
收藏
页码：E35 / E36
页数：2
相关论文
共 50 条
  • [21] Vinflunine in patients with advanced unresectable hepatocellular carcinoma and liver impairment
    Saliba, F.
    Paule, B.
    Adam, R.
    Castaing, D.
    Azoulay, D.
    Ogier, I.
    Pinel, M.
    Cadic, V.
    Delgado, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
    Ha, Yeonjung
    Lee, Danbi
    Shim, Ju Hyun
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Park, Sook Ryun
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Kang, Yoon-Koo
    Kim, Kang Mo
    ONCOTARGET, 2016, 7 (45) : 74303 - 74313
  • [23] Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
    El Dika, Imane
    Capanu, Marinela
    Chou, Joanne F.
    Harding, James J.
    Ly, Michele
    Hrabovsky, Anna D.
    Do, Richard K. G.
    Shia, Jinru
    Millang, Brittanie
    Ma, Jennifer
    O'Reilly, Eileen M.
    Abou-Alfa, Ghassan K.
    CANCER MEDICINE, 2020, 9 (20): : 7453 - 7459
  • [24] Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
    Iavarone, Massimo
    Cabibbo, Giuseppe
    Biolato, Marco
    Della Corte, Cristina
    Maida, Marcello
    Barbara, Marco
    Basso, Michele
    Vavassori, Sara
    Craxi, Antonio
    Grieco, Antonio
    Camma, Carlo
    Colombo, Massimo
    HEPATOLOGY, 2015, 62 (03) : 784 - 791
  • [25] Sorafenib in multifocal hepatocellular carcinoma and advanced liver dysfunction
    Pinter, Matthias W.
    Sieghart, Wolfgang
    Graziodei, Ivo
    Konigsberg, Robert
    Peck-Rodosavljevic, Markus
    HEPATOLOGY, 2007, 46 (04) : 410A - 410A
  • [26] Relationship of ethnicity and overall survival in patients treated with sorafenib for advanced hepatocellular carcinoma
    Peixoto, Renata D'Alpino
    Renouf, Daniel J.
    Gill, Sharlene
    Cheung, Winson Y.
    Lim, Howard J.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (04) : 259 - 264
  • [27] Impact of statin on the survival of patients with advanced hepatocellular carcinoma treated with sorafenib or lenvatinib
    Cho, Hyo Jung
    Han, Ji Eun
    Cheong, Jae Youn
    Kim, Soon Sun
    JOURNAL OF HEPATOLOGY, 2023, 78 : S572 - S572
  • [28] Sorafenib in unresectable hepatocellular carcinoma and advanced liver cirrhosis
    Pinter, M.
    Sieghart, W.
    Graziadei, I.
    Vogel, W.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S13 - S13
  • [29] Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma
    You-xin Ji
    Zhong-fa Zhang
    Ke-tao Lan
    Ke-ke Nie
    Chuan-xin Geng
    Shi-chao Liu
    Ling Zhang
    Xing-jun Zhuang
    Xiao Zou
    Lei Sun
    Zong-chun Zhang
    Chinese Medical Sciences Journal, 2014, 29 (01) : 7 - 14
  • [30] The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib
    Han, Ji Eun
    Kim, Jisu
    Cheong, Jae Youn
    Kim, Soon Sun
    Lim, Sun Gyo
    Yang, Min Jae
    Noh, Choong-Kyun
    Lee, Gil Ho
    Eun, Jung Woo
    Park, Bumhee
    Cho, Hyo Jung
    CANCERS, 2024, 16 (02)
12345